Literature DB >> 20118628

A twenty eight-day repeated dose toxicity study of black soybean extract in Sprague-Dawley rats.

Akihiro Hagiwara1, Norio Imai, Takamasa Numano, Hironao Nakashima, Seiko Tamano, Kazushi Sakaue, Kiyofumi Tanaka, Kazuo Yasuhara, Shim-Mo Hayashi.   

Abstract

This study was designed to evaluate any adverse effect of a hot water extract of black soybeans (Glycine max (L.) Merr.), when administered to both sexes of Crj:CD(SD)IGS rats at dietary levels of 0 (control), 0.5, 1.5 and 5.0% (6 rats/sex/group). During the study, the treatment had no adverse effects on clinical signs, survival, body weights, and food and water consumption, or on findings of ophthalmology, urinalysis, hematology, or blood biochemistry. Organ weights, gross pathology and histopathology exhibited no differences of toxicological significance between control and treated rats. Thus, the no-observed-adverse-effect level (NOAEL) of black soybean extract was concluded to be 5.0% (3,618 mg/kg body weight/day for males and 4,066 mg/kg body weight/day for females) from the present study.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20118628     DOI: 10.2131/jts.35.87

Source DB:  PubMed          Journal:  J Toxicol Sci        ISSN: 0388-1350            Impact factor:   2.196


  1 in total

1.  A phase II double-blinded study to evaluate the efficacy of EW02 in reducing chemotherapy-induced neutropenia in breast cancer.

Authors:  Yi-Ying Wu; Hsin-Yi Liu; Tzu-Chuan Huang; Jia-Hong Chen; Ping-Ying Chang; Ching-Liang Ho; Tsu-Yi Chao
Journal:  Oncol Lett       Date:  2015-07-14       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.